Clinical Trials | October 03, 2023
Zydus announces IND clearance of a novel Anti-PCSK9 candidate
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
Balaxi Healthcare Ecuador S.A.S. has become a Wholly Owned Subsidiary of the company
Dr. Karikó is the third Solvay Prize winner to become a Nobel Prize laureate
SigTuple’s AI100 with Shonit is the premier solution for AI assisted digital pathology
New Board of Directors and management team at Suven Pharma also appointed
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
The U.S. FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
Apollo's unparalleled clinical excellence is built on extensive experience of performing over 300,000 angioplasties and 200,000 cardiac surgeries
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de México, S.A. de C.V. becoming a wholly-owned subsidiary of the company.
Subscribe To Our Newsletter & Stay Updated
